Analyst Research

Quarterly Deferred Revenue Of Hansen Medical, Inc. (NASDAQ:HNSN) At $3.923 Millions

For the year completed 2015-12-31, Hansen Medical, Inc. (NASDAQ:HNSN) posted comprehensive income of $-0.21 millions. It was $-0.21 millions for the quarter closed 2015-12-31. Deferred revenue Deferred revenue for the fiscal ended 2015-12-31 came at $3.923 millions. For the quarter settled 2015-12-31 it was $3.923 millions. Deferred revenue – non-current […]

March 28, 2017 ·

Quarterly Deferred Revenue Of Qumu Corporation (NASDAQ:QUMU) At $10.413 Millions

For the year completed 2015-12-31, Qumu Corporation (NASDAQ:QUMU) posted comprehensive income of $-1.521 millions. It was $-1.521 millions for the quarter closed 2015-12-31. Deferred revenue Deferred revenue for the fiscal ended 2015-12-31 came at $10.413 millions. For the quarter settled 2015-12-31 it was $10.413 millions. Deferred revenue – non-current was […]

March 28, 2017 ·

Quarterly Deferred Revenue Of Intermolecular, Inc. (NASDAQ:IMI) At $1.533 Millions

For the year completed 2016-12-31, Intermolecular, Inc. (NASDAQ:IMI) posted comprehensive income of $-0.032 millions. It was $-0.032 millions for the quarter closed 2016-12-31. Deferred revenue Deferred revenue for the fiscal ended 2016-12-31 came at $1.533 millions. For the quarter settled 2016-12-31 it was $1.533 millions. Deferred revenue – non-current was […]

March 28, 2017 ·

Quarterly Deferred Revenue Of Insys Therapeutics, Inc. (NASDAQ:INSY) At $5.307 Millions

For the year completed 2012-12-31, Insys Therapeutics, Inc. (NASDAQ:INSY) posted comprehensive income of $-0.152 millions. It was $-0.152 millions for the quarter closed 2012-12-31. Deferred revenue Deferred revenue for the fiscal ended 2012-12-31 came at $5.307 millions. For the quarter settled 2012-12-31 it was $5.307 millions. Deferred revenue – non-current […]

March 28, 2017 ·

Quarterly Deferred Revenue Of Amicus Therapeutics, Inc. (NASDAQ:FOLD) At $8.504 Millions

For the year completed 2011-12-31, Amicus Therapeutics, Inc. (NASDAQ:FOLD) posted comprehensive income of $2.047 millions. It was $2.047 millions for the quarter closed 2011-12-31. Deferred revenue Deferred revenue for the fiscal ended 2011-12-31 came at $8.504 millions. For the quarter settled 2011-12-31 it was $8.504 millions. Deferred revenue – non-current […]

March 28, 2017 ·

Quarterly Deferred Revenue Of Crossroads Systems, Inc. (NASDAQ:CRDS) At $1.531 Millions

For the year completed 2016-10-31, Crossroads Systems, Inc. (NASDAQ:CRDS) posted comprehensive income of $0 millions. It was $0 millions for the quarter closed 2016-10-31. Deferred revenue Deferred revenue for the fiscal ended 2016-10-31 came at $1.531 millions. For the quarter settled 2016-10-31 it was $1.531 millions. Deferred revenue – non-current […]

March 28, 2017 ·